256.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
Bio-Rad's Management to Participate in Fireside Chat During 2025 - GuruFocus
Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference - Business Wire
Bio-Rad Laboratories – Vericheck ddPCR™ Empty-Full Capsid Kit - Labmate Online
Hemoglobinopathy Market Set to Witness Significant Growth - openPR.com
Elisa Analyzer Market Grows Due to Demand for Quick and Accurate - openPR.com
Bio-Rad: With Low Debt And A Stock Price Drop, Is The Company Undervalued? (NYSE:BIO) - Seeking Alpha
Proteomics Market to Reach $161.9 billion, Globally, by 2035 - openPR.com
Cell-Based Assay Market Top Players- Becton, Dickinson - openPR.com
How To Trade (BIO.B) - news.stocktradersdaily.com
Paper Diagnostics Market Set to Witness Significant Growth by 2025-2032 | Abbott (Alere Inc.), Bio-Rad Laboratories - openPR.com
Tissue Diagnostics Market to Reach $12.4 Billion by 2029, Growing at 7.0% CAGR - GlobeNewswire Inc.
Sample Preparation Market Grows with Automation and Diagnostic - openPR.com
Antimicrobial Susceptibility Testing Market Report Insights, - openPR.com
Molecular Diagnostics Market Sees Strong Growth Driven by Rise - openPR.com
Custom Antibody Market To Hit USD 1,230.09 Billion By 2032 | - openPR.com
Polymerase Chain Reaction Market Set to Witness Significant - openPR.com
Enzyme Linked Immunosorbent Assay Market Deep Research - openPR.com
Bio-Rad Reports First-Quarter 2025 Financial Results - ADVFN
Fund Update: First Pacific Advisors, LP added 214,705 shares of BIO-RAD LABORATORIES ($BIO) to their portfolio - Nasdaq
U.S. Hemoglobinopathy Market 2025-2032: Top Trends & Growth - openPR.com
One Step RT-qPCR Kits Market Top Players- Takara Bio Inc., - openPR.com
Laboratory Proficiency Testing Market Is Booming Worldwide | - openPR.com
Biodetection Market Deep Research 2025-2032 | Bio-Rad - openPR.com
Analysts Have Been Trimming Their Bio-Rad Laboratories, Inc. (NYSE:BIO) Price Target After Its Latest Report - Yahoo Finance
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2025 Earnings Call Transcript - Insider Monkey
Beyond the Balance Sheet: What SWOT Reveals About Bio-Rad Labora - GuruFocus
Bio-Rad Earnings: Revenue Declines Driven by Weak Academic Research Market; Guidance Lowered - Morningstar
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2024 Earnings Call Transcript - MSN
BIO: UBS Lowers Price Target But Maintains Buy Rating for Bio-Ra - GuruFocus
Bio-Rad targets 1.5%-3.5% revenue growth in 2025 amid operational improvements and new acquisitions - MSN
BIO: UBS Lowers Price Target But Maintains Buy Rating for Bio-Rad Laboratories | BIO Stock News - GuruFocus
Bio-Rad Laboratories (BIO) Price Target Revised by Citigroup | B - GuruFocus
Bio-Rad Laboratories (BIO) Price Target Revised by Citigroup | BIO Stock News - GuruFocus
Bio-Rad's Steady Business and Stake in Sartorius Driving Long-Term Value - Morningstar
RBC Capital Lowers Price Target for Bio-Rad Laboratories (BIO) | - GuruFocus
RBC Capital Lowers Price Target for Bio-Rad Laboratories (BIO) | BIO Stock News - GuruFocus
Bio-Rad (BIO) Target Price Cut by UBS Amid Macroeconomic Concerns | BIO Stock News - GuruFocus
Bio-Rad (BIO) Sees Price Target Reduced by Citi Analyst After Q1 Report | BIO Stock News - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Biosensors Market Future Business Opportunities 2025-2032 | - openPR.com
UBS Adjusts Price Target on Bio-Rad Laboratories to $310 From $355, Maintains Buy Rating - marketscreener.com
BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket - Yahoo Finance
Biomarker Testing Market: Trends, Growth, and Key Insights 2025 - openPR.com
Bio-Rad Laboratories Q1 Adjusted Earnings Rise, Revenue Falls - marketscreener.com
Bio-Rad Laboratories Inc (BIO) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo
Bio Rad Laboratories Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Bio-Rad: Q1 Earnings Snapshot - MySA
Bio-Rad Laboratories Reports Q1 2025 Financial Results - TipRanks
Bio-Rad Laboratories (BIO) Faces Revenue Challenges Amid Market Headwinds - GuruFocus
Bio-Rad Laboratories Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Bio-Rad Labs exceeds Q1 2025 earnings expectations - Investing.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):